ProShares Ultra Nasdaq Biotechnology BIB:NASDAQ

Last Price$46.86NASDAQ Previous Close - Last Trade as of 3:59PM ET 9/13/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$45.80 (1)
Ask (Size)$47.24 (2)
Day Low / HighN/A - N/A
Volume60.6 K
 

View portfolioPortfolio as of 07/31/2019

Top 5 SectorsTop 5 Holdings
Health Technology86.26%
Amgen Inc ORD7.63%
Commercial Services1.16%
Gilead Sciences Inc ORD7.17%
Other0.99%
Celgene Corp ORD6.67%
Health Services0.70%
Illumina Inc ORD5.20%
Process Industries0.04%
Vertex Pharmaceuticals Inc ORD5.04%
Concentration of Top 589.15% Concentration of Top 531.71% 

Fund Profile

Fund Strategy

The Fund seeks daily investment results, before fees and expenses, that correspond to two times the return of the Nasdaq Biotechnology Index. The Index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical.

Fund Category Sector Equity
Inception Date 04/07/2010
Manager Neches/Dave
Fund Classification Equity Leverage Funds
Managed Since 2013
Other Managed Funds   UYG  ROM  INPIX  BIPIX  URE

Lipper Leader Scorecard as of 08/31/2019

RatingTotal
Return
Consistent
Return
PreservationTax
Efficiency
Expense*
Overall Rating(# of funds in category)
191

187

12,229

191

69
3 Year Rating(# of funds in category)
191

189

12,229

191

69
5 Year Rating(# of funds in category)
164

162

10,466

164

59
10 Year Rating(# of funds in category)
N/A

N/A

N/A

N/A

N/A

Fund Highlights

Price Open$46.73
Previous Close$46.86
52 Week Range$36.05 - 70.82
Average Market Capitallization192.1 M
Shares Outstanding4.1 M
Net Asset ValueN/A
Total Net Assets$189.7 M
Total Expense Ratio0.95

Options Summary

Call Open Interest (1d)
Put Open Interest (1d)
Call Volume (1d)
Put Volume (1d)
Put Call Open Interest Ratio (1d)
Put Call Volume Ratio (1d)

Risk Analysis

Beta vs. S&P 5002.74
R-Squared vs. S&P 5000.60
Standard Deviation41.88%
Sharpe Ratio0.17